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2Institut Camille Jordan, Université de Lyon, Université Claude Bernard Lyon 1, CNRSUMR 5208, 43 Boulevard du 11 novembre 1918, 69622
Villeurbanne Cedex, France
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69007 Lyon, France
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Primary immune responses generate short-term ef-
fectors and long-term protective memory cells. The
delineation of the genealogy linking naive, effector,
and memory cells has been complicated by the lack
of phenotypes discriminating effector from memory
differentiation stages. Using transcriptomics and
phenotypic analyses, we identify Bcl2 and Mki67 as
a marker combination that enables the tracking of
nascent memory cells within the effector phase. We
then use a formal approach based on mathematical
models describing the dynamics of population size
evolution to test potential progeny links and demon-
strate that most cells follow a linear naive/early
effector/late effector/memory pathway. More-
over, our mathematical model allows long-term pre-
diction of memory cell numbers from a few early
experimentalmeasurements. Ourwork thus provides
a phenotypic means to identify effector and memory
cells, as well as amathematical framework to investi-
gate their genealogy and to predict the outcome
of immunization regimens in terms of memory cell
numbers generated.
INTRODUCTION
Primary antigenic insult by a pathogen or a tumor leads to the
activation of rare naive CD8 T cells that, under appropriate con-
ditions, expand tremendously and differentiate into cytotoxic ef-
fectors, eliminating pathogen-infected or tumor cells. Eventually,
the primary response terminates, leaving a most potent long-
lived memory population that rapidly protects in the event of a
subsequent re-encounter with the same antigen. Induction of
memory cells is the goal of vaccination, and understanding theCell Systems 4, 1–12
This is an open access article under the CC BY-Nprocess leading to their generation is thus important in that
context. Moreover, because the process of memory develop-
ment spans several weeks, the early ability to predict the number
of memory cells generated after an immunization would facilitate
the screening of candidate vaccines.
In the past decades, considerable work has been performed to
identify the cellular transition stages between naive and memory
cells, to delineate their genealogy and to highlight the molecular
processes and controllers that could be targeted for immuno-
intervention (Chang et al., 2014; Harty and Badovinac, 2008;
Kaech and Cui, 2012).
Two major antigen-primed populations emerge from naive
precursors: effectors that ensure immediate defense and eradi-
cation of the pathogen and a long-term protective memory pop-
ulation. Both can be distinguished from naive cells based on their
phenotype, as the expression of a few surface markers (for
example, CD44, CCL5, and CXCR3) is modified early after anti-
gen encounter. However, this modified expression is maintained
throughout the effector and memory stages and is thus inappro-
priate to identify memory cells that are generated during the
ongoing effector phase.
A number of other surface markers (CCR7, CD62L, KLRG1,
CD27, CD127, and CD28) that are only modified by a fraction
of effector or memory cells have been used alone or in combi-
nations to classify these antigen-primed cells into multiple sub-
sets that differ in some of their functional properties or in their
memory generation potential (Appay et al., 2008; Buchholz
et al., 2013; Chang et al., 2014; Jameson et al., 2015; Kaech
and Cui, 2012; Masopust et al., 2001; Sallusto and Lanzavec-
chia, 2001). Defining the lineage relationship between these
subsets is a key element in our comprehension of the memory
generation process. However, it does remain controversial
(Ahmed et al., 2009; Arsenio et al., 2015; Flossdorf et al.,
2015; Kaech and Cui, 2012). Indeed, putative genealogies
were proposed from non-quantitative approaches, such as
transfer experiments that identify populations enriched in pre-
cursors of given differentiation stages or molecular (transcrip-
tome or T cell receptor [TCR] repertoire) analyses that identify, March 22, 2017 ª 2017 The Authors. Published by Elsevier Inc. 1
C-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
A B Figure 1. Analysis of Longitudinal Tran-
scriptomics Data of Murine Primary CD8 T
Cell Responses from the Immunological
Genome Project Consortium
Transcriptomics data from spleenOT-I CD8 T cells
at D0–D106 after VSV-OVA, and at D0–D100 after
Lis-OVA infections, were clustered for similarities
in (A) and analyzed by a top score pair approach
in (B).
(A) Similarity analysis identifies four clusters
corresponding to naive, D5–D6, D8–D15, and
D45–D106 responders.
(B) Bcl2 (gray) and Mki67 (black) relative expres-
sion levels (means ± SEM) during the course of a
response to VSV (upper graph) and Listeria (lower
graph). Vertical bars mark boundaries between
naive, early effector, late effector, and memory
phases, as determined by the clustering in (A).
See also Figures S1 and S4 and Table S1.
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CD62L+ central (TCM) and CD62L– effector (TEM) memory
T cells, the two first subsets that were described in humans
and mice (Masopust et al., 2001; Sallusto et al., 1999), has
been the purpose of multiple studies. The generation of TEM
from primary TCM after repetitive stimulation and/or strong anti-
genic and inflammatory signals was proposed (Kaech and Cui,
2012), while the inversed relation, i.e., the generation of TCM
from TEM has also been reported (Wherry et al., 2003). More-
over, based on their TCR repertoire it was suggested that TCM
and TEM could represent separate developmental lineages
(Baron et al., 2003; Bouneaud et al., 2005).
More recently, CD127/KLRG1 expression has been used to
identifymemoryprecursorcells (MPECs)during theeffectorphase
and the genealogical links between CD127/KLRG1-defined
effector subsets havebeendefinedby transfer experiments (Joshi
et al., 2007). Results showed that CD127– KLRG1– early effector
cells give birth to both CD127– KLRG1+ short-lived effector cells
(SLECs), a terminally differentiated population destined to die,
and CD127+ KLRG1– MPECs (Kaech and Cui, 2012; Plumlee
et al., 2015). This large MPEC population present at the peak of
the response does not, however, strictly correspond to the mem-
ory population as it ismolecularly heterogeneous, containing both
effector cells and memory precursors cells (Arsenio et al., 2014;
Hand et al., 2007).
Herein, we revisited this question with a quantitative modeling
framework to establish a genealogy between phenotypically
defined subsets by assessing putative differentiation schemes
in their ability to simulate population count dynamics. We first
identify Bcl2 and Mki67 as phenotypic markers distinguishing
between co-existing effector and memory populations and
allowing the identification of nascent memory cells within
the heterogeneous MPEC population. Using mathematical
modeling, we demonstrate that the majority of cells follow a
linear naive/early effector/late effector/memory differentia-
tion pathway. This pathway can be followed by both central
CD62L+ and effector CD62L– lineages. Furthermore, we show
that only a few early experimental measurements suffice to2 Cell Systems 4, 1–12, March 22, 2017determine the parameter values of the mathematical model
and to allow simulation of subset dynamics to predict long-
term memory cell counts.
RESULTS
Transcriptome Analyses Reveal the Existence of Two
Differentiation Stages during the Effector Phase
To identify discriminative phenotypes between effector and
memory CD8 T cells, we sought molecules specifically ex-
pressed at given differentiation stages during a primary CD8
T cell response. To do this, we made use of transcriptomics
data published by the Immunological Genome Project Con-
sortium (GEO: GSE15907, www.immgen.org/) (Best et al.,
2013). These data encompass transcriptome analyses of OT-I
mouse TCR-transgenic (TCR-tg) CD8 T cells from naive to
memory stages following ovalbumin (OVA)-expressing Listeria
(Lis-OVA) and vesicular somatitis virus (VSV-OVA) infections. A
similarity-based hierarchical clustering identified four groups of
gene expression patterns corresponding to naive, day 5 to day
6 (D5-D6), D8-D15, and D45-D106 responders for both bacterial
and viral immunizations (Figure 1A). Thus, the effector phase
seems to part in two stages, one early (D5-D6) and one late
(D8-D15).
We then looked for pairs of genes that display the most
opposite expression patterns along the kinetics, using a top-
scoring pair approach (Geman et al., 2004). Among these, a
number of pairs was identified with a strong expression of
molecules notably associated with the cell cycle during the
early stage of the effector phase (Figure S1). Of note, the
widely used proliferation marker Mki67 (Starborg et al., 1996)
is expressed by effector but not by memory antigen-specific
CD8 T cells in humans following yellow fever and smallpox
vaccine administration, while Bcl-2 expression is conversely
restricted to the memory population (Miller et al., 2008). We
thus looked at the pattern of Mki67 and Bcl2 expression by
CD8 T cells during the course of a primary response in mice.
Transcripts encoding Mki67 are strongly induced during the
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http://dx.doi.org/10.1016/j.cels.2017.01.014early stage of the effector phase in response to VSV-OVA or
Lis-OVA, while Bcl2 expression is downregulated along both
effector phases (Figure 1B). In conclusion, data from the liter-
ature (Miller et al., 2008) and expression databases (Best
et al., 2013) indicate a biphasic effector stage and suggest
that Bcl2 and Mki67 could help to distinguish between effector
and memory cells.
Mki67/Bcl2 Co-expression Patterns Define Two
Effector and One Memory Cell Populations
We thus investigated Mki67/Bcl2 co-expression by CD8 T cells
during a primary response, in combination with CD44 expres-
sion that rapidly upregulates upon activation and thus distin-
guishes between naive and antigen-primed cells. To do this,
C57BL/6 mice were transferred with naive CD8 T cells from
F5 TCR-tg mice and subsequently immunized by intranasal
infection with an NP68-expressing vaccinia virus (VV-NP68).
Immunized hosts were regularly bled and F5 CD8 T cell re-
sponders were counted and analyzed for CD44/Mki67/Bcl2
co-expression.
During the course of this response, CD44+ virus-primed
F5 responders homogeneously adopted three successive
phenotypes (Mki67+ Bcl2–, Mki67– Bcl2–, and Mki67– Bcl2+)
as exemplified in Figure 2A. As expected, naive cells are
CD44– Mki67– Bcl2+ and rapidly decline beyond the detection
limit by D7 of the response (Figure 2B). Among CD44+ antigen-
primed cells, F5 CD8 responders are almost exclusively Mki67+
Bcl2– between D5 and D10 of the response, Mki67– Bcl2– cells
dominate the response around D15, and an Mki67– Bcl2+ pop-
ulation is detectable by D13 and virtually represents all cells by
D30 and later on (Figure 2B). Each phase of the response, as
identified by common transcriptomics signatures (Figure 1A),
is thus dominated by a population specifically identified by
its CD44/Mki67/Bcl2 phenotype. Furthermore, the cytolytic
effector function analyzed by Granzyme B expression is mostly
restricted to the CD44+ Bcl2– compartment (Figure S2A).
CD44+ Bcl2+ Mki67– cells display a low level of activation
(only 5% of the cells are Granzyme B+) but confer an improved
protection against a lethal viral challenge (Figure S2B). CD44+
Bcl2– and CD44+ Bcl2+ Mki67– cells thus functionally define
the effector and memory populations, respectively, and we
can propose a sequence of subset appearance (Figure 2C),
where naive and primed cells are distinguished by CD44
expression, effector and memory populations among CD44+
primed cells are discriminated by their level of Bcl2 expression,
and CD44+ Bcl2– effectors are split into early Mki67+ and late
Mki67– stages.
The same succession of CD44/Mki67/Bcl2-defined popula-
tions was observed in the blood (Figure 2), spleen, draining
lymph nodes, and the site of infection (lung) and following a sys-
temic intraperitoneal injection (data not shown), as well as when
following the F5 CD8 T cell response to a tumor immunization
(Figure 2D). Moreover, vaccinia-specific, non-TCR-tg cells iden-
tified by B8R-MHC-I multimer binding followed the same
sequence of differentiation (Figure 2E). Thus, the naive/early
effector/late effector/memory sequence defined here is not
characteristic of TCR-tg cells or of a given immunization regimen
but a general feature of murine CD8 T cell primary responses
in vivo.Mathematical Modeling Confirms the Existence of Two
Effector Differentiation Stages
The differentiation scheme in Figure 2C is solely based on the
successive dominance of the response by each subset. To
determine the potential genealogical links between these sub-
sets, we used mathematical modeling to evaluate the perfor-
mance of putative genealogical models at reproducing the quan-
titative kinetics of subset cell counts.We first assessed the ability
of the sets of ordinary differential equations driving the mathe-
matical models to reproduce cell-count dynamics of B8R-spe-
cific endogenous CD8 T cells (Figure 2E). Models were ranked
according to their ability to reproduce experimental dynamics
(smallest c2 values) and a statistical test (corrected Akaike Infor-
mation Criterion [AICc]) that, beyond considering the ability to
minimize c2, penalizes over-parameterized models (Hurvich
and Tsai, 1989). Details on mathematical modeling are given in
the STAR Methods.
We previously established aminimal mathematical model able
to simulate the dynamics of total CD8 T cells during a primary
response, considering a naive/effector/memory differentia-
tion scheme (Crauste et al., 2015; Terry et al., 2012). Given that
transcriptomics data and CD44/Mki67/Bcl2 phenotypes re-
vealed two effector phases, we modified our initial model to
take into account these two compartments (Figure S3A). To
allow comparison between three- and four-compartment
models, early (E) and late (L) cellular compartments were
summed up for both experimental and simulation results (Table
S1). Cell counts of naive (N), both early and late effectors
(EFF), and memory (M) compartments were then fitted simulta-
neously using PottersWheel MATLAB Toolbox, which fits the
time series of all three subsets together. According to the AICc
criterion (Table S1), which strongly penalizes over-parameter-
ized models, both models perform equally well. However, the
three-compartment N(E+L)M model poorly simulates effector
(c2EFF = 9.1) and memory (c
2
M = 7.9) cell dynamics (Table S1
and Figure S4). Thus, mathematical modeling supports the exis-
tence of the two effector stages highlighted by expression data.
Mathematical Models Support a Linear N/E/L/M
Differentiation Pathway
To assess several putative parenthood links between the four
cellular compartments defined by CD44/Mki67/Bcl2 expression
levels, we next compared several four-compartmentmodels (Fig-
ure S3) and thus fitted E and L cells separately (STAR Methods).
According to AICc values and Akaike weights, the linear NELM
model proves to be the best model to describe the data, with a
probability of 0.98 (Table 1). This is also true when the six top
models presented in Figure 3Awere comparedwith regard to their
ability to fit the data, depicted in Figure 2D, of the F5 response to a
tumor immunization (Table S2). Although other models have very
low probabilities to be the best models, we hereafter investigate
how they perform at simulating experimental data.
The linear NLEM model D and NL branching derivatives, in
which naive cells first differentiate into L effectors, yielded the
highest c2 and AICc values (Table 1). The only means to improve
their ability to reproduce experimental data is to allow L cells to
proliferate (data not shown), which is not in agreement with their
Mki67– phenotype (Starborg et al., 1996). Among others, models
in which M cells do not originate uniquely from the LCell Systems 4, 1–12, March 22, 2017 3
A
B
C
D E
Time Days Time Days
Time DaysTime Days
N
o.
 o
f C
el
ls
N
o.
 o
f C
el
ls
N
o.
 o
f C
el
ls
N
o.
 o
f C
el
ls
N
o.
 o
f C
el
ls
N
o.
 o
f C
el
ls
Pe
rc
en
ta
ge
Pe
rc
en
ta
ge
Figure 2. Identification of CD8 T Cell Differentiation Stages during a Primary Response
Naive CD45.1+ F5 TCR-tg CD8 T cells were transferred to CD45.2+ C57BL/6 congenic recipients, which were immunized the next day by intranasal infection with
VV-NP68 in (A), (B), and (E) or by subcutaneous injection with the tumor EL4-NP68 in (D). At the indicated time points, recipients were bled and F5 TCR-tg in (A),
(B), and (D), or endogenous B8R-specific in (E), CD8 T cell responders were identified by CD45.1 or B8R-multimer staining, respectively, and analyzed by flow
cytometry for CD44/Mki67 and Bcl2 co-expression.
(A) Representative images of Mki67/Bcl2 co-expression by CD44 + F5 responders at the indicated times. Numbers represent the percentages of cells in each
quadrant.
(B) Overlay of the percentages (left) and absolute numbers (right) of CD44– Mki67– Bcl2+ (blue), CD44+ Mki67+ Bcl2– (red), CD44+ Mki67– Bcl2– (green), and +
Mki67– Bcl2+ (purple) subsets at the indicated times.
(C) Sequence of appearance and phenotype of the four differentiation stages identified by CD44/Mki67/Bcl2.
(D and E) Absolute cell counts of CD44/Mki67/Bcl2 defined subsets among F5 responders to an EL4-NP68 immunization (D) or endogenous B8R-specific CD8
T cell responders to a VV infection (E).
One representative experiment out of three to four, with three to five mice in each group (mean ± SD, when depicted).
See also Figures S1 and S2 and Tables S1 and S2.
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Table 1. Comparative Analysis of All Four-Compartment Models
Modela No. of Pars.b c2c c2N c
2
E c
2
L c
2
M AICc
d Di
d wi
d
Linear Models
(A)e NELM 12 19.9 0.1 11.9 1.8 6.1 445 0 98
(B)e NMEL 11 45.2 0.1 6.6 2.3 36.2 459 14 0.1
(C)e NMLE 9 132.0 0.1 10.5 85.0 36.4 529 84 0
(D)e NLEM 9 186.5 3.8 90.2 89.5 2.9 583 138 0
Branching: NEL Models
(a)e NbEMbELM 13 20.0 0.1 11.9 1.8 6.2 460 15 0.05
(b)e bNMbNELM 13 20.2 0.1 11.9 1.9 6.3 460 15 0.05
(c)e bNMbN(bEMbELM) 14 20.5 0.1 12.1 1.9 6.4 481 36 0
(d)e NbEMbEL 13 22.0 0.1 10.7 1.7 9.5 462 17 0.02
(e)e bNMbN(bEMbEL) 14 22.2 0.1 10.7 2.0 9.4 482 37 0
Branching: NM Models
(f)e bNMbNEL 10 49.0 0.0 10.6 2.9 35.5 453 8 1.7
(g)e NbMEbML 11 123.9 0.1 2.5 85.0 36.4 537 92 0
Branching: NL Models
(h)e bNEMbNLM 10 170.5 0.1 47.8 88.4 34.2 575 130 0
(i)e bNEbNLM 10 170.7 0.1 47.8 88.4 34.4 575 130 0
(j)e bNEMbNL 11 180.6 3.8 89.5 86.9 0.4 594 149 0
(k)e bNMbNLEM 9 186.5 3.8 90.2 89.5 2.9 583 138 0
(l)e NbLMbLEM 10 186.5 3.8 90.2 89.5 2.9 591 146 0
(m)e bNMbN(bLMbLEM) 10 188.6 0.2 87.2 87.0 14.2 593 148 0
For distances between best simulations and biological data (c2 values) and the statistical test (AICc) the smaller the value, the better the model. Best
values are shown in bold. See STAR Methods for c2, AICc, and wi calculations.
aSchematic representations are given in Figure S3.
bNumber of significant parameters.
cc2 = c2N + c
2
E + c
2
L + c
2
M.
dAICc is for corrected Akaike Information Criterion (Hurvich and Tsai, 1989), Di is the difference between the minimal value of AICc (here 445) and the
value of the model; and wi are the Akaike weights (Burnham and Anderson, 2002), in percentages.
eNames correspond to those given in Figure S3 and are explained in its legend. See also Figures S3 and S5 and Table S3.
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performmuchworse than the NELMmodel. Model f, which ranks
second based on AICc and generatesMcells only fromNcells, is
unable to fit data on M cell counts (Figure S5A). Model B, which
ranks third based on AICc and assumes a linear NMEL pathway,
simply does not generate anyM cells (Figure S5B), and its rank is
mostly due to its ability to generate dynamics at the cost of un-
physiological values for parameters mLE and mPE (Table S3).
Among the six models with a probability greater than 0.01%
(arbitrary threshold) to be the best model (Figure 3A), five models
display the N/E/L (i.e., NEL) sequence and three models
display the NELM sequence (A, a, and b). For the latter, it is
noticeable that the differentiation rates of either naive (dNM %
104 day1) or early effectors (dEM % 10
3 day1) in memory
cells are much smaller than those of late effectors (dLM 
0.025 day1, Table S3). Thus, even though our results do not
exclude the possibility of generating some memory cells directly
from naive or early effectors on top of the NELM backbone, they
indicate, with a very high probability, that most memory cells
differentiate along the linear N/E/L/M pathway (Figure 3).
In conclusion, mathematical modeling establishes that during
primary responses, naive cells (N, CD44– Mki67– Bcl2+) differ-
entiate into proliferating early effectors (E, CD44+ Mki67+
Bcl2–) that return to quiescence as late effectors (L, CD44+Mki67– Bcl2–), from which the majority of memory cells (M,
CD44+ Mki67– Bcl2+) emerges (Figures 2C and 3B).
Subsets Defined by CD127/KLRG1, but Not by CD62L
Expression Levels, Define Differentiation Stages Linked
by a Genealogy
Many genealogical filiations during primary CD8 T cell responses
have been proposed based on phenotypicmarkers (Chang et al.,
2014; Harty and Badovinac, 2008; Kaech and Cui, 2012). For
instance, based on the downregulation of CD62L expression
on the majority of cells during the effector phase (Figure 4A),
some models have proposed that CD62L+ TCM memory cells
are generated from CD62L– effectors or early TEM. However,
the extensive cellular expansion occurring during the effector
phase translates into an expansion/contraction dynamics of
both CD62L– and CD62L+ effectors (Figure 4A and Kedzierska
et al., 2007), making it difficult not to consider that TCM may orig-
inate from CD62L+ effectors. Interestingly, both CD62L+ and
CD62L– cells were able to follow a complete NELM pathway,
as defined by CD44/Mki67/Bcl2 co-expression (Figure 4B).
Thus, although our results cannot exclude interconversions be-
tween CD62L+ and CD62L– cells, they show that TEM and TCM
can develop as separate lineages in line with previous results
(Baron et al., 2003; Bouneaud et al., 2005).Cell Systems 4, 1–12, March 22, 2017 5
Figure 3. Best-Performing Differentiation
Models
(A) Schematic version of the six top models. Dif-
ferentiation pathways between N, E, L, and M
cellular compartments are represented by plain
arrows. Circular dotted arrows depict proliferation
and red circles represent cellular compartments in
the common NEL backbone. AICc and Akaike
weight values are indicated for each model (See
Table 1).
(B) Full description of the NELM model. The path-
ogen P and CD8 T cell differentiation stages are
presented in boxes. Double arrows represent the
differentiation paths, black arrows represent evo-
lution to death, and the dotted black arrows
represent proliferation. Positive feedback is de-
picted with red arrows.
(C) The set of ordinary differential equations driving
the NELM model. Let F0(t) be the time derivative of
F(t), where F˛ {N; E; L;M; P}. Parameters appear in
red, i.e., mX is the natural death rate of X cells. mXY
reflects the death rate of X cells under the influence
of Y cells. dXY is the differentiation rate of X cells
into Y cells. rX is the proliferation rate of X cells.
See also Figures S3 and S5 and Tables S2 and S3.
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TCR-tg CD8 T cells stimulated by Listeria in vivo, it has
recently been proposed that memory cells could appear
before effectors in the differentiation pathway (Buchholz
et al., 2013). However, the proposed pathway, which does
not harbor negative feedback loops, can reproduce the dy-
namics of populations in terms of relative percentages
(Buchholz et al., 2013) but fails to reproduce experimental
cell counts, notably their decrease after D12 of the response
(Figure 4C). In conclusion, CD62L-based phenotypic defini-
tions of CD8 T cell populations may rather represent different
functional classes of cells than populations with parental
relationships.
Conversely, the CD127/KLRG1-based SLEC/MPEC paradigm
seems to represent a true genealogy as suggested by transfer ex-
periments (Joshi et al., 2007) and the fact that it can be success-
fully describedby thecorrespondingdynamicalmodel (Figure4D).6 Cell Systems 4, 1–12, March 22, 2017CD44+ Mki67– Bcl2+ Cells
Represent EmergingMemory CD8 T
Cells among MPEC
MPEC, although enriched in memory pre-
cursors (Joshi et al., 2007), define a het-
erogeneous population (Arsenio et al.,
2014; Hand et al., 2007), and we thus
investigated the relationships between
the herein-defined NELM pathway and
the SLEC/MPEC paradigm. We observed
that MPEC peak and dominate the
response of F5 cells at D8 (Figure 5A),
as observed for P14 TCR-tg cells
in response to VV (Joshi et al., 2007).
However, Mki67/Bcl2/CD127/KLRG1 co-
expression analyses revealed that the
MPEC population was mostly composedof Mki67+ Bcl2–early effectors at D8, Mki67– Bcl2– late effectors
at D13, and then slowly enriched itself in Mki67– Bcl2+ memory
cells that constitute virtually all MPEC cells at D46. Thus, while
contracting, the MPEC population slowly enriches itself in mem-
ory cells, as defined by their Mki67/Bcl2 phenotype (bottom line
in Figure 5A). Conversely, the Mki67– Bcl2+ memory population
steadily increases in size and is completely restricted to the
CD127+ KLRG1– MPEC phenotype from its very appearance
around D8 (bottom line in Figure 5B). Thus, the CD44+ Mki67–
Bcl2+ phenotype identifies emerging memory CD8 T cells within
the heterogeneous MPEC population.
The NELM Mathematical Model Can Predict Long-Term
Memory Cell Counts from Early Subset Measurements
Considering the ability of our model to fit to experimental data,
we next tested its capacity to achieve long-term prediction of
memory cell quantities. Indeed, the first aim of vaccine
A
B
C
D
Figure 4. Subsets Defined by CD127/
KLRG1, but Not by CD62L Expression Levels
Define Differentiation Stages Linked by a
Genealogy
Naive CD45.1+ F5 TCR-tg CD8 T cells were
transferred to CD45.2+ C57BL/6 congenic re-
cipients, which were immunized the next day by
intranasal infection with VV-NP68. At the indicated
time points, spleens were collected and F5 CD8
T cell responders were analyzed by flow cytometry
for: (A–C) CD27, CD62L, CD44, Mki67, and Bcl2
co-expression, to determine: (A) the percentages
(left-hand graph) and absolute cell counts (right-
hand graph) of CD62L+ (black curves) and
CD62L (brown curves) total F5 responders; (B)
the number of early effector (red), late effector
(green), and memory (purple) cells in the CD62L+
(left hand graph) and CD62L (right hand graph)
compartments; and (C) the number of TCMp
(blue), TEMp (black), and TEFF (red) populations
represented by points with SD error bars on
the right-hand graph together with the best simu-
lation (curves) obtained with the corresponding
TCMp/TEMp/TEFF model published in Buch-
holz et al. (2013) and depicted on the left.
(D) CD44, CD127, and KLRG1 co-expression, to
determine the number of EEC (blue), MPEC (black),
and SLEC (red) populations represented by points
with SD error bars on the right-hand graph together
with the best simulation (curves) obtained with
the corresponding N(bEEC/SLEC)(bEEC/MPEC)
paradigm depicted on the left. Plain and dotted
arrows represent differentiation and proliferation,
respectively. The equations driving the models
presented in (C) and (D) are given in the STAR
Methods.
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http://dx.doi.org/10.1016/j.cels.2017.01.014candidates is to induce asmanymemory CD8 T cells as possible
to ensure subsequent protection. One can consider, based on
lymphocytic choriomeningitis virus infection data (Badovinac
et al., 2002; Murali-Krishna et al., 1998), that 5%–10% of cells
present at the peak of the response will remain as the memory
cell pool. However, it is experimentally tricky to catch the exact
time of the peak of the response and, depending on immuniza-
tion conditions, such as the cytokinemilieu the extent of contrac-
tion varies (Badovinac et al., 2000; Blattman et al., 2003; Harty
and Badovinac, 2002). For instance, in the experiments depicted
in Figures 2D and 2E, the ratio between the number of memorycells at the last experimental point and
the number of responders at the captured
time of the peak is 1.6% and 16%,
respectively. Thus, applying a 5%–10%
rule would have under- or overestimated
the number of memory cells generated
and blurred the difference between the
two systems. We thus questioned
whether the NELM model could help to
predict the number of memory cells
generated.
To do this, we used sets of experimental
measures restricted to early time points to
estimate the model parameter values andgenerate cellular dynamics that we compared with simulations
obtained with all experimental data. Those included measure-
ments at D4, D6, D7, D8, D13, D15, D22, and D28. Using only
data up to D7 or D8 is not sufficient to obtain good simulations
of the total CD8 and memory cell dynamics (Figures 6A and 6B)
or of the effector cell subsets (Figures S6A and S6B). However,
when extending the measurements up to D13, it was possible
to generate simulations of total cell and subset dynamics that fit
experimental results and are very similar to the simulations ob-
tained using data from all time points (Figures 6C and S6C). More-
over, extending the measurements to D15 did not significantlyCell Systems 4, 1–12, March 22, 2017 7
A
B
CD127-KLRG1- (EEC)
CD127-KLRG1+ (SLEC)
CD127+KLRG1- (MPEC)
Mki67+Bcl2- (Early 
effector)
Mki67-Bcl2- (Late 
effector)
Mki67-Bcl2+ (Memory)
D4 D6 D8 D13 D21 D46
D4 D6 D8 D13 D21 D46
Mki67+Bcl2- (Early effector)
Mki67-Bcl2- (Late effector)
Mki67-Bcl2+ (Memory)
CD127-KLRG1- (EEC)
CD127-KLRG1+ (SLEC)
CD127+KLRG1- (MPEC)
Figure 5. Relationship between Differentia-
tion Stages as Defined by CD127/KLRG1 or
Mki67/Bcl-2 Co-expression
Naive CD45.1+ F5 TCR-tg CD8 T cells were
transferred to CD45.2+ C57BL/6 congenic re-
cipients, which were immunized the next day by
intranasal infection with VV-NP68. At the indicated
time points, the spleens were collected and F5
CD8 T cell responders were analyzed by flow
cytometry for CD127/KLRG1/Mki67 and Bcl2
co-expression.
(A) Pie chart representation of the mean pro-
portions of splenic early effector (red), late effector
(green), andmemory (purple) stages, as defined by
Mki67/Bcl2 co-expression, among EEC, SLEC,
and MPEC cells, as defined by CD127/KLRG1 co-
expression. All pie surfaces are proportional to the
size of the population at the indicated time points.
(B) Pie chart representation of the mean pro-
portions of splenic EEC (blue), SLEC (red), and
MPEC (black) stages, as defined by CD127/
KLRG1 co-expression, among early effector, late
effector, and memory cells, as defined by Mki67/
Bcl2 co-expression. All pie surfaces are propor-
tional to the size of the population at the indicated
time points.
One representative of two independent experi-
ments, with three to five mice in each group
is shown.
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tioned whether we could reduce the number of measurements
and estimate parameters values fromonlyD6,D8, andD13 exper-
imental data. Although the effector subset dynamics were less
well simulated than with five experimental points (Figure S6E),
this did not affect the long-term prediction of memory cell quan-
tities (Figure 6E). In conclusion, measuring naive, early, and late
effectors, and memory cell counts, as defined by their CD44/
Mki67/Bcl2 phenotype at three to five early time points (with three
to five mice per group) is sufficient to correctly predict long-term
memory cell counts with the NELM model.
DISCUSSION
The current study revisited the sequence of events accompa-
nying the differentiation of naive CD8 T cells upon antigenic8 Cell Systems 4, 1–12, March 22, 2017stimulation in vivo and in silico. Three in-
dependent approaches: unsupervised
clustering of transcriptomics data (Fig-
ure 1), surface phenotyping (Figure 2),
and mathematical modeling (Table S1)
demonstrated the effector phase
should be considered as a two-step dif-
ferentiation stage. The identification of
CD44+ Mki67+ Bcl2– early effector,
CD44+ Mki67– Bcl2– late effector and
CD44+ Mki67– Bcl2+ memory popula-
tions was common to TCR-Tg and non-
transgenic cells, in infectious and tu-
moral contexts and in all tested organs
(blood, spleen, draining lymph nodes,and lung). It thus represents a common feature of murine pri-
mary CD8 T cell responses. Interestingly, it matches the pheno-
type of day-15 effector and month-6 memory cells induced by
vaccination in humans (Miller et al., 2008), and it may thus be
generalized to human and possibly other species. The expres-
sion of Mki67+, a marker of cycling cells (Starborg et al., 1996),
by early effector cells fits with the tremendous early expansion
observed during the beginning of this phase and is in agree-
ment with data showing that activated cells need to perform
at least five cell cycles to acquire a memory generation poten-
tial (Opferman et al., 1999). The second effector stage corre-
sponds to quiescent Mki67– cells. The functional significance
of the CD44+ Mki67– Bcl2– differentiation step requires further
investigation. Our preliminary results could not highlight major
differences between early and late effector cells, at least in
terms of cytokine production (data not shown), although a
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Figure 6. Predictive Simulations of Memory CD8 T
Cell Counts
(A–E) Mice were immunized by intranasal infection with
vaccinia and recipients were bled at the indicated time
points. Endogenous B8R-specific CD8 T cell responders
were analyzed by flow cytometry for CD44, Mki67, and
Bcl2 co-expression to calculate absolute numbers of total
(blue, left-hand) and memory (purple, right-hand) cells
(mean ± SD). The parameter values of the NELM model
were estimated by fitting experimental data from: (A)
D4–D7; (B) D4–D8; (C) D4–D13; (D) D4–D15; or (E) D6, D8,
and D13; and cell dynamics were simulated (plain curves).
Overlaid dashed curves correspond to the simulations
obtained using all D4–D28 experimental data to estimate
parameter values of the NELM model. Experimental time
points used for fitting are inserted in graphs, displayed in
black and highlighted by a shaded background.
See also Figure S6.
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Emerging memory cells (CD44+ Mki67– Bcl2+) are character-
ized by de novo expression of the anti-apoptotic Bcl2 mole-
cule, which fits with the long-lived potential of these cells.
Interestingly, using a Bcl2-reporter mouse model, others have
shown that memory differentiation potential is correlated withBcl2 re-expression among MPEC cells at the
peak of the response (Dunkle et al., 2013).
CD8 T cells have been subdivided into sub-
sets of cells sharing a similar phenotype
(Chang et al., 2014; Harty and Badovinac,
2008; Kaech and Cui, 2012). Herein, we show
that such phenotypically defined subsets can
represent functional classes rather than steps
in a differentiation process, even when succes-
sively observed. This is the case of CD62L-
based central and effector lineages (Figures
4A and 4B). Conversely, the CD127/KLRG1-
based SLEC/MPEC paradigm seems to repre-
sent a true genealogy, as suggested by trans-
fer experiments (Joshi et al., 2007) and
because it can be successfully described by
the corresponding dynamical model (Fig-
ure 4D). However, we confirmed that MPEC
is a large, composite (in terms of Mki67/Bcl2
expression) population at the peak of the
response that only slowly enriches itself in
memory cells thereafter. Still, we could identify
nascent memory cells among MPEC with the
CD44+ Mki67– Bcl2+ discriminative pheno-
type. This phenotypic identification of memory
cells during the effector phase will help to
investigate the molecular cues regulating
commitment to either cell fate.
Based on our phenotypic definition of naive,
early and late effectors, and memory popula-
tions, we used mathematical modeling of cell
population sizes to investigate genealogical re-
lationships between these subsets. Indeed,
transfer experiments can only assess the pres-ence of precursors within a given population without quantifica-
tion (Hand et al., 2007; Kaech et al., 2003; Kedzierska et al.,
2007). They can thus only access the destiny of cells that sur-
vive the transfer and the subsequent differentiation process,
making it difficult to establish parental links between global
populations. Conversely, through mathematical formalism weCell Systems 4, 1–12, March 22, 2017 9
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cally defined populations and compare their abilities to quanti-
tatively reproduce the time evolution of population sizes, thus
identifying genealogies that can explain the observed dy-
namics. We previously published mathematical models of pri-
mary CD8 T cell responses (Crauste et al., 2015; Terry et al.,
2012) based on a three-compartment differentiation scheme.
These models were adapted from those developed in seminal
studies (Antia et al., 2005; De Boer et al., 2001; Ganusov,
2007), with modifications to allow a single set of ordinary differ-
ential equations to simulate total CD8 T cells counts, thanks to
feedback mechanisms (Crauste et al., 2015; Terry et al., 2012).
We herein modified our original models to take two effector
compartments into account (Table S1 and Figure S4).
First, we found that models in whichmemory cells differentiate
only directly from naive cells, as proposed in Buchholz et al.
(2013), poorly reproduced our experimental data (Table 1) and
were unable to simulate memory cell dynamics (Figures S5A
and S5B), indicating that naive cells need first to differentiate
into effectors before memory generation (Bannard et al., 2009).
The discrepancy between the two formal approaches could
result from the fact that the TCMp/TEMp/effector model (Fig-
ure 4D), which does not harbor negative feedback loops, is not
able to account for both expansion and contraction phases.
Although it can reproduce the dynamics of populations in terms
of relative sizes of the populations and total CD8 counts up to D8
of the response (Buchholz et al., 2013), it fails to simulate the
contraction that occurs thereafter (Figure 4D) and hence the
generation of memory cells.
Second, the NELM linear model was identified as the best
model among all tested models. There has been intense debate
on whether differentiation pathways are linear or branching (Ar-
senio et al., 2015; Flossdorf et al., 2015). In the current study,
branching models either failed to describe the generation of M
cells (FigureS5AandS5B)or thedecayofEorLcells (FigureS5C),
when L cells represent terminally differentiated cells. This ex-
tends the results obtained in initial modeling studies that showed
that terminally differentiated, undividing effectors cannot explain
the dynamics of CD8 T cell counts (Antia et al., 2005; Ganusov,
2007). Among models including additional N/M and/or E/M
branches on top of the linear N/E/L/M genealogy (a–c) it
is, however, noticeable that differentiation rates of memory cells
from naive, early, or late effectors indicate that the vast majority
of cells follow the linear N/E/L/M pathway. It would be
interesting to identify priming conditions able to favor the differ-
entiation ofmemory cells directly from naive or early effector pre-
cursors (e.g., manipulating inflammation levels [Cui et al., 2009;
Harty and Badovinac, 2008]) and to characterize the properties
of memory cell populations resulting from different genealogical
tracks. Our results also highlight a possible branching between
CD62L+ central and CD62L–effector lineages (Figure 4B) but,
as CD62L-based phenotypes do not define genealogically linked
differentiation stages, it is difficult to assess at which stage the
branching between the two classes from CD62L+ naive cells
occurs.
Importantly, we could simulate memory cell counts with the
NELM model from only a few early measurements of cell subset
counts. Measurements on a (D6–D13) time frame encompassing
the expansion peak yield sufficient information to correctly10 Cell Systems 4, 1–12, March 22, 2017estimate parameter values of the model and therefore generate
memory population dynamics and predict long-term memory
cell counts. Thus, the NELM mathematical model allows predic-
tion in these experimental conditions. Other experimental condi-
tions, manipulating controllers of the response (such as antigen,
route, inflammation, or knockout contexts), will need further
investigation to establish the robustness and predictive capac-
ities of the differentiation models based on CD44/Mki67/Bcl2
phenotypes.
In conclusion, we propose a dynamical model of CD8 T cell
primary responses based on previously unidentified phenotypic
markers that define four differentiation stages. It will facilitate
precise investigations of the molecular actors and immunization
conditions that control effector and memory cell generation. Its
translation to mathematical formalism allows the prediction,
from a few experimental measurements during the effector
phase, of the quantity of memory cells that will be generated. It
could thus help to reduce time and cost issues in the process
of candidate vaccine screening in preclinical studies.STAR+METHODS
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Antibodies
FITC-coupled anti-mouse Bcl-2 BioLegend (London, UK) Clone BCL/10C4 Cat#633504; RRID:
AB_2028394
BV605-coupled anti-mouse CD45.1 BioLegend Clone A20 Cat#110737; RRID:
AB_11204076
Alexafluor700-coupled anti-mouse CD45 BioLegend Clone 30-F11 Cat#103128; RRID:
AB_493715
BV510-coupled anti-mouse CD62L BioLegend Clone MEL-14 Cat#104441; RRID:
AB_2561537
PerCP.Cy5.5-coupled anti-mouse Mki67 eBioscience (Paris, France) Clone SolA15 Cat#46-5698-82; RRID:
AB_11040981
PE.Cy7-coupled anti-mouse CD8 eBioscience Clone 53.6.7 Cat#25-0081-82; RRID:
AB_469584
APC-coupled anti-mouse CD27 eBioscience Clone LG.7F9 Cat#17-0271-82; RRID:
AB_469370
APC-coupled anti-mouse KLRG1 eBioscience Clone 2F1 Cat#17-5893-82; RRID:
AB_469469
PE-coupled anti-human GranzymeB ThermoFisher Scientific (TFS, Illkirch,
France)
Clone GB12 Cat#MHGB04; RRID:
AB_10372671
Biotin-coupled anti-mouse CD127 eBioscience Clone A7R34 Cat#13-1271-82; RRID:
AB_466588
VioBlue-coupled anti-mouse CD44 Miltenyi (Paris, France) Clone IM7.8.1 Cat#130-102-443
Chemicals, Peptides, and Recombinant Proteins
NaN3 Sigma-Aldrich (Lyon, France) Cat#S2002
Deposited Data
Longitudinal gene expression data of OT-I
cells responding to Listeria and VSV
infections
Immgen Consortium (Best et al., 2013) https://www.ncbi.nlm.nih.gov/geo/query/
acc.cgi?acc=GSE15907
Experimental Models: Cell Lines
EL4-NP68 Dr. T.N. Schumacher (de Brito et al., 2011) Parental strain RRID: CVCL_0255
Experimental Models: Organisms/Strains
C57BL/6 mice Charles River Lab. (CRL, Saint-Germain-
Nuelles, France)
C57BL6/J
https://www.jax.org/strain/000664
CD45.1 + C57BL/6 mice CRL B6.SJL-PtprcaPepcb/BoyCrl
http://www.criver.com/products-services/
basic-research/find-a-model/ly51-mouse
F5 CD45.1+ TCR-Tg mice Generated by crossing in our facility (Jubin
et al., 2012)
B6.SJL-PtprcaPepcb/BoyCrl-Tg(CD2-
TcraF5,CD2-TcrbF5)1Kio/Jmar
RRID of parental strain:MGI:3760628
VV-NP68 Sir Pr. A.J. McMichael (Jubin et al., 2012) Parental strain: Western Reserve Vaccinia
Virus UniProt Taxon: 10254
Software and Algorithms
FlowJO TreeStar (Ashland OR, USA) RRID: SCR_008520
Bioconductor 2.10 release
http://www.bioconductor.org/packages/
2.10/BiocViews.html - ___Software
RRID:SCR_006442
tspair BioConductor 2.10 release (Geman
et al., 2004)
http://www.bioconductor.org/packages/
2.10/bioc/html/tspair.html
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Reagent or Resource Source Identifier
Potter-Wheel 3.1 Matlab’s toolbox MathWorks (Montbonnet, France)
(Maiwald and Timmer, 2008)
http://www.potterswheel.de/;
RRID: SCR_001622
Other
FlowCount Fluorospheres Beckman Coulter (Nyon, Switzerland) Cat#7547053
FoxP3 TF Staining Buffer Set eBioscience Cat#00-5523-00
efluor780-coupled FVD eBioscience Cat#65-0865
PE-coupled streptavidin BD Biosciences (Le Pont de Claix, France) Cat#554061; RRID: AB_10053328
Dulbecco’s Phosphate Buffer Saline (PBS) TFS Cat#14190250
Fetal Calf Serum (FCS) BioWest (Nuaillé, France) Cat#S1810
ACK lysis buffer TFS Cat#A1049201
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Further information and requests for reagents may be directed to and will be fulfilled by Lead Contact Christophe Arpin, CIRI
(INSERM-U1111/CNRS-UMR5308) (christophe.arpin@inserm.fr). VV-NP68 utilization is protected by a MTA between MRC, London,
U.K. and INSERM, Bron, France, and therefore cannot be disseminated.
EXPERIMENTAL MODELS
C57BL/6 mice (C57BL6/J) and CD45.1+ C57BL/6 mice (B6.SJL-PtprcaPepcb/BoyCrl) were purchased from CRL. F5 TCR-tg mice
recognizing the NP68 epitope were crossed to a CD45.1+ C57BL/6 background (B6.SJL-PtprcaPepcb/BoyCrl-Tg(CD2-
TcraF5,CD2-TcrbF5)1Kio/Jmar; (Jubin et al., 2012). They have been crossed at least 13 times on the C57BL6/J background. All
mice were homozygous adult 6-8-week-old at the beginning of experiments. They were healthy and housed in our institute’s animal
facility under Specific Pathogen-Free conditions. Age- and sex-matched littermates or provider’s delivery groups, which were naive
of any experimental manipulation, were randomly assigned to experimental groups and co-housed at least for one week prior to
experimentation. Animals were maintained in ventilated enriched cages at constant temperature and hygrometry with 13hr/11hr
light/dark cycles and constant access to 21 kGy-irradiated food and acid (pH = 3 ± 0.5) water.
2x105 naive CD8 T cells from CD45.1+ F5 mice were transferred by retro-orbital injection in, briefly 3% isoflurane-anaesthetized,
6-8-week-old congenic CD45.2+ C57BL/6mice. The day after deeply Xylazin/Ketamin-anaesthetized recipient mice were inoculated
intra-nasally with 2x105 pfu of a vaccinia virus expressing the NP68 epitope (VV-NP68) and provided by Pr. A.J. McMichael; alterna-
tively, briefly 3% isoflurane-anaesthetized recipients were subcutaneously inoculated with 2.5x106 EL4 lymphoma cells expressing
the NP68 epitope (EL4-NP68) and provided by Dr. T.N.M. Schumacher (de Brito et al., 2011). All experimental procedures were
approved by an animal experimentation ethics committee (CECCAPP; Lyon, France), and accreditations have been obtained
from French government.
METHOD DETAILS
Phenotypic Analyses
Mice were bled at intervals of at least 7 days or sacrificed for organ collection. Blood and spleen cell suspensions were cleared of
erythrocytes by incubation in ACK lysis solution (TFS). Cells were then incubated with efluor780-coupled Fixable Viability Dye (eBio-
science) to label dead cells. All surface stainings were then performed for 45minutes at 4C in PBS (TFS) supplemented with 1% FBS
(BioWest) and 0.09% NaN3 (Sigma-Aldrich). Cells were fixed and permeabilized with the Foxp3-fixation and permeabilization kit
(eBioscience) before intra-cellular staining for one hour to overnight. The following mAbs(clones) were utilized: Bcl2(BCL/10C4),
CD45.1(A20), CD45(30-F11) and CD62L(MEL-14) from Biolegend, Mki67(SolA15), KLRG1(2F1), CD127(A7R34), CD27(LG.7F9)
and CD8(53.6.7) from eBioscience, GranzymeB(GB12) from TFS and CD44(IM7.8.1) from Miltenyi. Samples were acquired on a
FACS LSR Fortessa (BD biosciences) and analyzed with FlowJo software (TreeStar).
Cell Culture
The EL4-NP68 cell line is maintained for a maximum of 4 weeks at 37C in 5%CO2 incubator, in DMEM (TFS) medium supplemented
with 6% FBS (BioWest), 2 mM L-glutamin, 50 g/ml gentamicin, 10 mM (pH 7.4) HEPES buffer (all from TFS), and 50 M 2-ME (Sigma-
Aldrich). Cells were diluted 1/10 on Mondays and Wednesdays and 1/20 on Fridays.e2 Cell Systems 4, 1–12.e1–e4, March 22, 2017
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Gene expression data from ImmGen (Best et al., 2013; https://www.immgen.org/) were recovered from Gene Expression Omnibus
(http://www.ncbi.nlm.nih.gov/geo/; GEO: GSE15907). Data were processed and analyzed with R and Bioconductor (Release 2.10)
packages. Samples corresponding to the kinetics of OT-I in vivo responses to VSV and Listeriawere hierarchically clustered accord-
ing to their expression profiles. Expressions throughout the four main clusters corresponding to naive (D0), early effector (D0.5-D6),
late effector (D8-D15) and memory (D45-D106) phases were compared and the Top Scoring Pair method (Geman et al., 2004; tspair
Bioconductor package) was applied to identify pairs of genes with most opposite expression patterns.
Mathematical Modeling
Models
All mathematical models assessed to fit CD44/Mki67/Bcl2 expression data (Figure S3) contain five variables denoted P for pathogen
counts and N, E, L, and M for cellular counts, the dynamics of which are described by nonlinear ordinary differential equations
(Figure 3C). The following general assumptions have been made:
d Naive cells differentiate only in the presence of the pathogen.
d Only Mki67+ cells proliferate (Starborg et al., 1996).
d Both Mki67- and Mki67+, Bcl2- populations (E and L) exert cytolytic functions. Indeed, both populations harbour significant
intra-cellular contents of Granzyme B, as compared to M cells (Figure S2A).
d All cellular compartments and pathogen die with constant rates. The pathogen is subject to E and L cell cytoxicity, as well as E
and L cells themselves to take into account competition for nutrients and fratricide killing (Kemp et al., 2004; Su et al., 1993).
The deterministic model assessed to fit CD44/CD27/CD62L expression data in Buchholz et al.; Figure 4C) is the almost linear
differentiation sequence TCMp / TEMp / TEFF, given by:
N
0 ðtÞ=  d0;1NðtÞ  d0;2NðtÞ ; (Equation 1)T
0
CMðtÞ=d0;1NðtÞ+ l1TCMðtÞ  d1TCMðtÞ ; (Equation 2)0
TEMðtÞ=d0;2NðtÞ+d1TCMðtÞ+ l2TEMðtÞ  d2TEMðtÞ (Equation 3)0
TEFFðtÞ=d2TEMðtÞ+ l3TEFFðtÞ : (Equation 4)
The mathematical model assessed to fit CD44/CD127/KLRG1 expression data (Figure 4D) was written to describe the differenti-
ation of SLEC or MPEC, both from EEC, and is given by:
N
0 ðtÞ=  mNNðtÞ  dNEPðtÞNðtÞ ; (Equation 5)E
0 ðtÞ= dNEPðtÞNðtÞ þ ½rEPðtÞ  mEEðtÞ  dES  dEMEðtÞ ; (Equation 6)0 
S ðtÞ= dESEðtÞ+ rSPðtÞ  mSSðtÞ  m0S

SðtÞ ; (Equation 7)M
0 ðtÞ= dEMEðtÞ  mMMðtÞ ; (Equation 8)0 
P ðtÞ= rPPðtÞ  mPSSðtÞ  mPMMðtÞ  m0P

PðtÞ : (Equation 9)
In all cases, the initial conditions were as follows: we assume that there is no CD44+ (E, L, M, EEC, SLEC, MPEC, TCMp, TEMp and
Effectors) cell prior to the infection (primary response). The initial number of CD44- cells is fixed (N(0) = 8090 cells). This value has
been evaluated in several immunization models and proved to be robust. Since pathogen dynamics is normalized (Crauste et al.,
2015), the initial amount of pathogen is given by P(0) = 1.
Parameter Value Estimation
All parameters are assumed to be nonnegative and those associated with differentiation are positive. We fitted experimental data
and estimated parameter values with PottersWheel (Maiwald and Timmer, 2008) Matlab’s toolbox (MathWorks). All data are fittedCell Systems 4, 1–12.e1–e4, March 22, 2017 e3
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populations are summed up before fitting (Table S1). Thus, the objective is to minimize the c2 function defined byc2(p) = c2N(p) + c
2
EFF(p) + c
2
M(p), (Equation 10)
where
c2XðpÞ=
XT
i = 1

xi  Xðti;pÞ
si
2
; (Equation 11)
with X = N (CD44-Mki67-Bcl2+), EFF (CD44+Bcl2-), or M (CD44+Mki67-Bcl2+), and p being the set of parameters that are estimated,
xi the i-th observation ofX (which is here amean value), si the standard deviation of X at t = ti, and T the number of experimental points.
We also fitted all 4-compartment models with E and L populations separately (Table 1), the objective thus being to minimize the c2
function defined by:c2(p) = c2N(p) + c
2
E (p) + c
2
L (p) + c
2
M(p). (Equation 12)
The initial models, consisting in the description of a given differentiation pathway and including all realistic proliferation and death
processes that could be considered (Figure 3B), have been gradually simplified by progressively eliminating negligible parameters, as
long as the c2 values improved and the differentiation pathway was preserved.
QUANTIFICATION AND STATISTICAL ANALYSIS
Results Presentation
Where depicted, graph bars describe means ± standard deviation.
Blood Cell Enumeration
The volume of sampled blood (VS) was precisely measured and a given number (F) of FlowCount Fluorospheres (Beckman Coulter)
was added to each sample. The ratio between the numbers of FACS-analyzed CD8 T cell responders (RFACS) and fluorospheres
(FFACS) was then used to recalculate the concentration of CD8 T cell responders in the blood (CR), considering:
CR =
F
VS
3
RFACS
FFACS
; (Equation 13)
and total numbers of circulating cells were calculated considering 2 mL of blood per mouse.
Statistical Tests for Model Selection
To compare models with different numbers of parameters, we used the corrected Akaike information criterion (Hurvich and Tsai,
1989) to avoid selection of over-parameterized models:
AICc= 2p 2logðLÞ+ 2pðp+ 1Þ
s p 1= 2p+c
2  2logðCÞ+ 2pðp+ 1Þ
s p 1 ; (Equation 14)
where p is the number of parameters, L the likelihood (expressed as a function of c2 and a constantC depending on the sample), and s
the size of the experimental sample.
In order to compare models based on their AICc values, we computed Di values, defined asDi = AICci  AICcmin, (Equation 15)
and Akaike weights wi (Burnham and Anderson, 2002), given by
wi =
expðDi=2ÞP
jexpðDj

2Þ ; (Equation 16)
that provide ‘‘weight of evidence’’ in favor of a model and can be interpreted as probabilities for a given model to be the best for the
data, given the data and a set of models (Burnham and Anderson, 2002).e4 Cell Systems 4, 1–12.e1–e4, March 22, 2017
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Figure S1. Related to Figure 1. Expression profiles of molecules potentially involved in cell cycle and up-regulated 
during the early stage of the effector phase.  
Analysis of longitudinal Immgen consortium's transcriptomics data from spleen OT-I CD8 T cells at D1, D2, D6, D8, 
D10, D15, D45 and D100 after Lis-OVA infections were analyzed by a top scoring pair approach (Geman et al., 2004). 
Depicted is the expression level (mean ± SEM) of a selection of genes specifically up-regulated during the early stage 
of the effector phase (red curves) and of their best opposite partners (blue curves), showing early and transitory up-
regulation of molecules involved in either cell cycle progression (A), chromatin organization (B), mitotic chromosome 
condensation (C), spindle assembly and organization (D), and kinesin or kinesin binding (E). Vertical bars mark 
boundaries between naive, early effector, late effector and memory phases, as determined by the clustering in Figure 1A.
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Figure S2. Related to Figure 2. Functional assessment of antigen-primed, Mki67/Bcl2-defined subsets.  
Naive CD45.1+ F5 TCR-tg CD8 T cells were transferred to CD45.2+ C57BL/6 congenic recipients that were immunized 
the next day by intra-nasal infection with VV-NP68.  
(A) Expression of Granzyme B. At the indicated time points, mice were bled and endogenous F5 CD8 T cell responders 
were analyzed by flow cytometry for CD44, Mki67 and Bcl2 co-expression and intra-cellular Granzyme B content of 
CD44+ subsets defined by Mki67/Bcl2 co-expression. One representative out of 4 experiments with 3 to 5 mice per 
group is shown (mean ± SD). 
(B) Cross-protective capacity against an influenza infection. Four months after infection, F5 memory CD8 T cells 
(over 98% CD44+Mki67-Bcl2+) were purified by FACS-sorting and 1.2x105 cells were transferred to secondary 
hosts (black curve), in parallel with recipients receiving the same amount of naive F5 cells (blue curve). Recipients 
were infected the next day with a semi-lethal (106 TCID50) dose of an influenza H1N1 virus expressing NP68 and 
monitored by daily weighing. In this transfer context, where no other actors of the adaptive immunological 
memory, such as neutralizing antibodies, are present, the protective capacities of memory CD8 T cells is 
specifically and stringently assessed. Animals were culled when losing over 20% of their initial weight and 
survival curves are shown. One representative out of 3 experiments with 8 to 15 mice per group is shown. 
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Figure S3. Related to Figures 3, S4 and S5 and all Tables. Schematic representation of the differentiation pathways 
mathematically modeled. 
Differentiation pathways between N(=CD44-Mki67-Bcl2+), E(=CD44+Mki67+Bcl2-), L(=CD44+Mki67-Bcl2-) and 
M(=CD44+Mki67-Bcl2+) cellular compartments are represented by plain arrows. Circular dotted arrows depict 
proliferation and red circles represent common backbones in a group of branching models. Names of models in blue 
depict the differentiation pathways, e.g. NLEM correspond to the N→L→E→M pathway. Each branch in the names is 
described starting with b, e.g. NbMEbML depicts N→M, followed by either M→E or M→L.  
Linear models (A). Branching models (B). See Tables 1, S1 and S2 for comparisons of the different models.  
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Figure S4. Related to Figures 1 and S3A and Table S1. Representation of the simulations from the best fits of NELM 
and N(E+L)M models.  
Mice were immunized by intra-nasal infection with vaccinia and recipients were bled at the indicated time points. 
Endogenous B8R-specific CD8 T cell responders were analyzed by flow cytometry for CD44, Mki67 and Bcl2 co-
expression. Plain lines represent the simulated (Blue, N = CD44-Mki67-Bcl2+; Red, E+L = CD44+Bcl2-; Purple, M = 
CD44+Mki67-Bcl2+) populations and points with SD error bars the experimental data. Best fits of the N→E→L→M 
four- (A) and N→(E+L)→M three- (B) compartment models. 
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Figure S5. Related to Figures 3A and S3, and Tables 1 and S3. Simulations yielded by the best fits of models with a 
terminal L compartment compared to those from the NELM model. 
Mice were immunized by intra-nasal infection with vaccinia and recipients were bled at the indicated time points. 
Endogenous B8R-specific CD8 T cell responders were analyzed by flow cytometry for CD44, Mki67 and Bcl2 co-
expression to calculate absolute cell numbers (mean ± SD). Parameter values were then estimated by fitting experimental 
counts of naive (blue), early effector (red), late effector (green) and memory (purple) subsets. NELM (plain lines) is 
compared to alternative differentiation pathways:  
(A) bNMbNEL model (f), starry lines  
(B) NMEL model (B), starry lines 
(C) NbEMbEL model (d), and bNMbN(bEMbEL) model (e), dotted lines. 
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Figure S6. Related to Figure 6. Simulation of naive and effector subsets dynamics with the NELM model fitted using 
different experimental value sets.  
Mice were immunized by intra-nasal infection with vaccinia and recipients were bled at the indicated time points. 
Endogenous B8R-specific CD8 T cell responders were analyzed by flow cytometry for CD44, Mki67 and Bcl2 co-
expression to calculate absolute numbers of naive (blue, left-hand), early effector (red, center) and late effector (green, 
right-hand) cells (mean ± SD). The NELM model's parameter values were estimated by fitting experimental data from: 
(A) D4-D7; (B) D4-D8; (C) D4-D13; (D) D4-D15; or (E) D6, D8 and D13; and subset dynamics were simulated (plain 
curves). Overlaid dotted curves correspond to the simulations obtained using all D4-D28 experimental data to estimate 
NELM model's parameter values. Experimental time points used for fitting are inserted in graphs, displayed in black 
and highlighted by a shaded background.  
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Table S1. Related to Figures 1, S3A and S4 
Comparative analysis of Naive®Effector®Memory linear models with three- and four-
compartments.  
Modela  #par.b  c2 c  c2N c2EFF c2M  AICcd 
3 compartment model 
N(E+L)Me  8  17.1  0.1 9.1 7.9  321 
4 compartment model 
NELMe  9  3.5  0.1 2.3 1.0  321 
For distances between best simulations and biological data (c2 values) and the statistical test (AICc) 
the smaller the value, the better the model. Best values are shown in bold. See Experimental 
Procedures for c2 and AICc calculations. 
a: Schematic representations are given in Figure S3A. 
b: Number of significant parameters. 
c: c2 = c2N+c2EFF+c2M. 
d: AICc is for corrected Akaike Information Criterion (Hurvich and Tsai, 1989). 
e: Names correspond to those given in Figure S3A and are explained in its legend. 
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Table S2. Related to Figures 2D and 3A. 
Comparative analysis of the 6 top models in Figure 3A in their ability to fit the data depicted in Figure 
2D of the F5 response to a tumor immunization. 
Modela  #par.b  c2 c  c2N c2E c2L c2M  AICd Δi
d wid 
A)e=NELM  9  4.7  0 1.1 3.1 0.5  348 0 99.3 
f)e=bNMbNEL  9  14.7  0 4.5 5.7 4.5  358 10 0.7 
B)e=NMEL  10  11.8  0.1 1.2 5.8 4.7  487 139 0 
a)e=NbEMbELM  10  4.6  0 1.1 3.2 0.3  479 131 0 
b)e=bNMbNELM  10  4.8  0 1.2 3.0 0.5  480 132 0 
d)e=NbEMbEL  10  1.6  0 0.9 0.5 0.3  476 128 0 
For distances between best simulations and biological data (c2 values) and the statistical test (AICc) the 
smaller the value, the better the model. Best values are shown in bold. See Experimental Procedures for c2, 
AICc and wi calculations. 
a: Schematic representations are given in Figure S3. 
b: Number of significant parameters. 
c: c2 = c2N+c2E+c2L +c2M. 
d: AICc is for corrected Akaike Information Criterion (Hurvich and Tsai, 1989), Δi is the difference between 
the minimal value of AICc (here 348) and model’s value; and wi are the Akaike weights (Burnham and 
Anderson, 2002), in percentages. 
e: Names correspond to those given Figure S3A and are explained in its legend. 
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Table S3. Related to Figures 3, S3 and S5 and to Table 1. 
Values of parameters yielding the best fit of experimental data by the top six models.  
Parametera    Unit  Model A)b Model f) b Model B) b Model a) b Model b) b Model d) b
    NELM  bNMbNEL NMEL  NbEMbELM bNMbNELM NbEMbEL         
    Rank 1c  Rank 2 c  Rank 3 c  Rank 4 c  Rank 5 c  Rank 6 c      
µN        d-1   0.75  0.69  0.68  0.75  0.75  0.74   
dNE        d-1   0.009  0.015  n.a.
d  0.009  0.009  0.011   
dNM        d-1   n.a.
d  0.023  0.052  n.a.d  10-3 e  n.a.d   
rE        d-1   0.64  0.42  0.53  0.65  0.64  0.68   
µEE        10-6 cell-1d-1  21.5  4.4  19.5  5.8  21.5  0   
µEL        10-6 cell-1d-1  0  0  0  1.5  0  9.6   
dEM        d-1   n.a.
d  n.a.d  n.a.d  10-4 e  n.a.d  6.3 10-3   
dEL        d-1   0.59  0.47  0.62  0.63  0.59  0.69   
µLE        10-8 cell-1d-1  3.6  0  1756.3  3.7  3.6  23   
µLL        10-6 cell-1d-1  7.5  8.7  0  7.3  7.5  5.2   
µL        d-1   0  0  0.14  0  0  0.16   
dLM        d-1   0.025  n.a.
d  n.a.d  0.026  0.025  n.a.d   
µM        d-1   0  0  0  0  0  0   
dME        d-1   n.a.
d  n.a.d  0.147  n.a.d  n.a.d  n.a.d 
rP        d-1   0.15  0.14  0.20  0.13  0.15  0.12   
µPE        10-7 cell-1d-1  1.8  0  134.6  2.4  1.8  6.1   
µPL        10-5 cell-1d-1  1.8  15.6  0  1.4  1.8  0.3 
µP        10-2 d-1  5.5  0.14  0.11  1.9  5.5  0.7  
Each model was fitted to experimental data with PottersWheel (Maiwald and Timmer, 2008) Matlab's toolbox that simultaneously fits all 
cellular compartments (See Experimental Procedures). The values of the parameters leading to the smallest c2 values are presented. The 
differentiation rates towards M cells are shown in red and outlier, un-physiological values in bold. 
a: µX is the natural death rate of X cells. µXY is the death rate coefficient of X cells under the influence of Y cells (the death rate of X cells 
is then µXYY). dXY is the differentiation rate of X cells into Y cells. rX is the proliferation rate of X cells. 
b: See Figures 3A or S3 
c: see Table 1 
d: Not applicable 
e: Lowest value allowed by the fitting procedure 
 
 
